ropidoxuridine
ropidoxuridine: 1 clinical trial tracked.
ropidoxuridine evidence translation
What we can confirm
1 tracked trial
No verified listed company relationship
What it means
AI will separate confirmed drug evidence from unknown company context.
What to watch
Watch trial status, endpoints, and the next source-backed update.
BioSniper AIPage context preserved
Prepared research question
What is verified about ropidoxuridine, and what remains unknown?
Run cited research
Traceable citations · Unknowns marked
Clinical Trial Registry Records (1)
Phase 2 Study of Ropidoxuridine as a Radiation Sensitizing Agent During Radiotherapy in Patients With Newly Diagnosed IDH-Wildtype Glioblastoma With Unmethylated MGMT Promoter
Primary endpoint: Number of patients treated with oral ropidoxuridine at dose levels of 960 and 1200 mg once daily, with treatment-related adverse events assessed by CTCAE v5.0.
InterventionalRandomizedopen30 targetStarted 2024-09Completion 2025-126 sites · United StatesShuttle Pharmaceuticals, Inc.